Pharma Journalist -

SMi Reports: SMi Group are delighted to announce that registration is open for the 5th Annual Lyophilization USA conference, taking place October 23rd-24th in Boston. Despite being a…
Read More...

SMi Reports: Novartis, SKAN and Taro Pharmaceuticals to speak on containment and banding strategies at the inaugural HPAPI USA conference, taking place on October 21st-22nd in Boston…
Read More...

Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity. It will bring together Gubra’s…
Read More...

Particle Sciences, a Lubrizol LifeSciences company and pharmaceutical contract development and manufacturing organization (CDMO), has broadened its Drug Enforcement Administration (DEA)…
Read More...

Merz, a global leader in neurotoxin therapy, announced the European approval of Xeomin (incobotulinumtoxinA) for the symptomatic treatment of chronic sialorrhea (drooling) due to…
Read More...

Bayer AG and Foundation Medicine, Inc. announced a global collaboration for the development and commercialization of NGS-based companion diagnostics.  This agreement allows for…
Read More...

Armas Pharmaceuticals Inc. and Micro Labs USA, Inc. have announced, the forming of a strategic collaboration to bring select multisource injectable products to the U.S. market. The…
Read More...

Allergan plc and Gedeon Richter Plc. announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for VRAYLAR (cariprazine) for…
Read More...

Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private…
Read More...

Acerus Pharmaceuticals Corporation announced that it has signed a patent license agreement with the University of Texas at Austin for technology related to the nasal administration of…
Read More...